Published in Thromb Haemost on July 01, 1998
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding. Crit Care (2006) 0.91
Overview of the human pharmacokinetics of recombinant activated factor VII. Br J Clin Pharmacol (2007) 0.87
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets. Am J Pathol (2011) 0.85
Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma. Crit Care (2005) 0.85
Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP). J Thromb Haemost (2014) 0.80
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet (1993) 6.08
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial--Europe Study Group. N Engl J Med (1996) 4.45
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet (1999) 3.81
Low molecular weight heparin in prevention of perioperative thrombosis. BMJ (1992) 3.36
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet (2000) 3.25
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation (1996) 3.00
An insulator element and condensed chromatin region separate the chicken beta-globin locus from an independently regulated erythroid-specific folate receptor gene. EMBO J (1999) 2.68
Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev (2006) 2.46
Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med (1997) 2.40
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation (1998) 2.35
EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed (1997) 2.26
Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials. J Intern Med (2000) 2.12
Could institutional clinical trials exist in Europe? EUTERP Pilot Study Group. European Trial of Estrogen/progestin Replacement treatment in Post-menopause. Lancet (1999) 2.01
Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J (1998) 1.97
Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. Eur J Clin Pharmacol (2000) 1.93
[The value of anesthesia consultation in relation to the single preanesthetic visit]. Ann Fr Anesth Reanim (1999) 1.87
Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ (1992) 1.72
Individualizing aspirin therapy for prevention of cardiovascular events. JAMA (1998) 1.71
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab (1996) 1.58
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost (2007) 1.53
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50
Drug prescription in young children: results of a survey in France. Epicrèche Research Group. Eur J Clin Pharmacol (1991) 1.49
Survey of the attitudes to management of acute pyelonephritis in children. GEP. Pediatr Nephrol (1994) 1.47
Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. Eur Heart J (1990) 1.44
Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine (2001) 1.44
Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry (2000) 1.42
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation. Proc Natl Acad Sci U S A (1985) 1.37
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation (1997) 1.34
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]. Therapie (2000) 1.34
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J Gene Med (2000) 1.23
Pseudomembranous colitis probably due to rifampicin. Lancet (1980) 1.22
Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology (1997) 1.21
Smoking cessation with behaviour therapy of acupuncture--a controlled study. Behav Res Ther (1983) 1.20
A pharmacokinetic simulation model for ivabradine in healthy volunteers. Eur J Pharm Sci (2000) 1.19
Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18
A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J Theor Biol (2006) 1.17
Erythropoietin structure-function relationships. Identification of functionally important domains. J Biol Chem (1994) 1.14
Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13
Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J (2002) 1.11
The N-terminal fingers of chicken GATA-2 and GATA-3 are independent sequence-specific DNA binding domains. EMBO J (1997) 1.11
Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin. J Biol Chem (1984) 1.11
Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials. Stat Med (1998) 1.10
INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. Therapie (1995) 1.10
Revisiting the effect compartment through timing errors in drug administration. Trends Pharmacol Sci (1998) 1.09
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A. Haemophilia (2004) 1.08
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood (1993) 1.05
Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group. Hypertension (1995) 1.04
One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03
Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction. Analysis of data from the EMIP study. European Myocardial Infarction Project. Eur Heart J (1997) 1.02
Inter-study variability in population pharmacokinetic meta-analysis: when and how to estimate it? J Pharm Sci (2000) 1.01
Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults. Vaccine (2001) 1.00
Trial summary software. Comput Methods Programs Biomed (2000) 1.00
Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis. Eur J Clin Pharmacol (1994) 0.99
Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences. J Virol (2001) 0.99
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99
Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications. Angiology (1988) 0.98
Phosphodiesterase III inhibitors for heart failure. Cochrane Database Syst Rev (2005) 0.98
Quality of health information about depression on internet. Level of evidence should be gold standard. BMJ (2001) 0.97
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis (1998) 0.97
[Letter: Cholostatic jaundice caused by carbimazole]. Nouv Presse Med (1973) 0.97
Complex formation of human thrombospondin with osteonectin. Eur J Biochem (1988) 0.96
Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum (1998) 0.96
Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol (1983) 0.96
Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virologic status of children attending day-care centers. Respiration (1994) 0.96
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol (1996) 0.94
High level of tyrosine protein kinase in a murine lymphoma cell line induced by Moloney leukemia virus. EMBO J (1982) 0.94
Differential binding of the Bombyx silk gland-specific factor SGFB to its target DNA sequence drives posterior-cell-restricted expression. Mol Cell Biol (1997) 0.93
Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation (2000) 0.92
Hemoglobin South Florida. New variant with normal electrophoretic pattern mistaken for glycosylated hemoglobin. Diabetes (1986) 0.91
Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins. Thromb Res (1979) 0.90
Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. Biochemistry (2001) 0.89
Isolation of thrombospondin released from thrombin-stimulated human platelets by fast protein liquid chromatography on an anion-exchange Mono-Q column. J Chromatogr (1984) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Meta-analysis and multiple publication of clinical trial reports. Lancet (1992) 0.89
Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project. Stroke (2000) 0.88
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Sick population--treated population: the need for a better definition. The VALIDATA Group. Eur J Clin Pharmacol (1991) 0.88
Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg (1993) 0.87